These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4807573)

  • 1. The protective effect of antisera against leukaemia in vivo--a reappraisal.
    Hersey P
    Br J Cancer Suppl; 1973 Aug; 1():11-8. PubMed ID: 4807573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of antileukemia sera prepared by immunization with leukemia cells admixed with normal antigen-blocking sera.
    Smith PJ; Robinson CM; Reif AE
    Cancer Res; 1974 Jan; 34(1):169-75. PubMed ID: 4129197
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity of rabbit antisera against mouse leukaemias in vitro.
    Reif AE; Kim CA
    Immunology; 1971 Jun; 20(6):1087-97. PubMed ID: 5105043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens.
    Motta R
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):161-7. PubMed ID: 4315341
    [No Abstract]   [Full Text] [Related]  

  • 5. Proportional absorption. A method for determination of the relative specificity of antisera prepared against cells.
    Reif AE; Robinson CM
    Immunology; 1975 Jan; 28(1):199-205. PubMed ID: 1090519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies variability in antibody-dependent cellular cytotoxicity (ADCC).
    Zighelboim J; Gale RP
    J Immunol; 1974 Oct; 113(4):1145-50. PubMed ID: 4528608
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
    Todd RF; Stulting RD; Berke G
    Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the mode of action of heterologous antileukemic sera. Growth of syngeneically transplanted leukemias in serum-treated sublethally irradiated mice (author's transl)].
    Mileck J
    Arch Geschwulstforsch; 1975; 45(1):40-5. PubMed ID: 1156118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA; Guy K; Davies DA
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract]   [Full Text] [Related]  

  • 12. HL-A reagents from primates. I. Antigen preparation, immunization, and preliminary analysis of sera.
    Sanderson AR; Welsh KI
    Transplantation; 1973 Oct; 16(4):304-12. PubMed ID: 4200798
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity.
    Gale RP; Zighelboim J
    J Immunol; 1975 Mar; 114(3):1047-51. PubMed ID: 1167565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.
    Kedar E; Otiz de Landazuri M; Fahey JL
    J Immunol; 1974 Jan; 112(1):26-36. PubMed ID: 4812174
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterologous antiserum to a subpopulation of thymocytes and lymphomas in rats.
    Moriuchi T; Kasai M; Kobayashi H
    Gan; 1979 Dec; 70(6):825-8. PubMed ID: 317055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of heterologous antisera against mouse leukemias.
    Milleck J; Pasternak G
    Medicina (B Aires); 1976; 36(5):457-62. PubMed ID: 1004205
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophage dependent protection of tumour cells.
    Hersey P; MacLennan IC
    Immunology; 1973 Feb; 24(2):385-93. PubMed ID: 4714057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral antibodies in the host directed against tumor cells after suppression of ascites tumor by heteroimmune sera.
    Rao VS; Sirsi M
    Cancer Res; 1971 Aug; 31(8):1153-8. PubMed ID: 5095980
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of lymphocyte-mediated cytotoxicity (51Cr-release) by antisera preabsorbed with various cells.
    Sendo F; Aoki T; Buafo CK
    J Natl Cancer Inst; 1974 Mar; 52(3):769-75. PubMed ID: 4857026
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between blocking and unblocking activity and tumor growth in vivo.
    Sjögren HO; Bansal SC
    Natl Cancer Inst Monogr; 1972 Dec; 35():231-5. PubMed ID: 4349148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.